Are you Dr. Ralstin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2251 Dubois Dr
Warsaw, IN 46580Phone+1 574-269-2777Fax+1 317-274-2277
Summary
- Dr. Matthew Ralstin, MD is a board certified ophthalmologist in Warsaw, Indiana. He is currently licensed to practice medicine in Indiana.
Education & Training
Indiana University School of MedicineResidency, Ophthalmology, 2008 - 2011- Indiana University School of Medicine/Methodist HospitalInternship, Transitional Year, 2007 - 2008
- Indiana University School of MedicineClass of 2007
Certifications & Licensure
IN State Medical License 2009 - 2025- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 31 citationsPGE(2) in pancreatic cyst fluid helps differentiate IPMN from MCN and predict IPMN dysplasia.C. Max Schmidt, Michele T. Yip-Schneider, Matthew Ralstin, Sabrina C. Wentz, John M. DeWitt
Journal of Gastrointestinal Surgery. 2008-01-01 - 34 citationsSuppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivoMichele T. Yip-Schneider, Huangbing Wu, Matthew Ralstin, Constantin T. Yiannoutsos, Peter A. Crooks
Molecular Cancer Therapeutics. 2007-06-01 - 31 citationsParthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest.Matthew Ralstin, Earl A. Gage, Michele T. Yip-Schneider, Patrick J. Klein, Eric A. Wiebke
Molecular Cancer Research. 2006-06-01
